Insider trade

CFO sold ~$78K of PBYI shares in the open market

Traded Jul 6, 2026 · Filed Jul 9, 2026

Why it stands out

The money chief of Puma Biotechnology sold $78K of Puma Biotechnology shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CFO$25K–$100KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$77,557

Shares × reported transaction price

Timing vs results

60 days after results of May 7, 2026, 31 days before results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Scheduled in advance3mo ago

Scheduled in advance3mo ago

4mo ago

Compensation award — excluded from discretionary-purchase analysis.